DR. MICHAEL POIESZ

WOODLANDS MEDICAL SPECIALISTS
Department of Hematology-Oncology

FELLOWSHIP
Fellowship in Hematology-Oncology
New York University Medical Center
New York, New York

RESIDENCY 
Residency in Internal Medicine 
Tufts Medical Center
Boston, Massachusetts 

MEDICAL SCHOOL
Doctorate of Medicine
State University of New York at Syracuse College of Medicine
Syracuse, New York

AFFILIATIONS/ACHIEVEMENTS

  • Board-Certified Physician
  • State Licensed in Florida and Alabama

  • Bone Marrow Biopsy and Aspiration Procedure Certification

RESEARCH & PUBLICATIONS

  • Poiesz BJ, Poiesz MJ, Choi D. The Human T-cell Lymphoma/Leukemia Viruses (2003). Cancer Investigation; 21(2): 253-77.
  • Poiesz BJ, Poiesz MJ, Choi D. Human T-cell Lymphoma/Leukemia Virus-Associated T-cell Lymphoma and Leukemia, in Neoplastic Diseases of the Blood, 4th edition (2003). Wiernick, PH et al, eds. Cambridge University Press. New York, NY. Pg. 141-63.
  • Poiesz BJ, et al. Prevalence of HTLV-I-Associated T-cell Lymphoma (2001). American Journal of Hematology; 66: 32-8.
  • Anish T, Perzova R, Abbot L, Benz P, Poiesz M, et al. LGL Leukemia and HTLV (2010). AIDS Research and Human Retroviruses; 26(1): 1-8.
  • Thomas A, Perzova R, Abbott L, Benz P, Poiesz MJ, et al. The absence of HTLV 3 and 4 in patients with large granular lymphocytic leukemia (YEAR). 
  • Poiesz MJ, Cho Di, Hengst J, Ehrlich G, Dube S, and Poiesz BJ. Rational Development of Serologic Assays for anti-HTLV Antibodies. Presented in Abstract form (#4187) at the 12/05 ASH Meetting.
  • Development of Novel Therapeutic Strategies for the Treatment of EBV Related Malignancies
  • A Phase I Study of Histone Deacetylase Inhibitors and Ganciclovir for Patients with Recurrent and/or Metastatic Nasopharyngeal Carcinoma
  • Monitoring of quantitative Epstein-Barr Viral load during standard treatment and follow up of locally advanced Nasopharyngeal Carcinoma
  • Literature Review and Case Report of Extraskeletal Myxoid Chondrosarcoma
  • Hematology Oncology Grand Rounds
    • OX40 is a Potential Molecular Target for the Treatment of Adult T-Cell Lymphoma
    • NF-kB Pathway Inhibition in the Treatment of T-cell ALL
    • Exploiting Epigenetic Phenomenon in the Treatment of EBV-Associated Malignancies
  • Lecture Series
    • Malignant Epidural Spinal Cord Compression
    • How to Call a Consult
    • Initial Management of Aggressive B-Cell Non-Hodgkins Lymphoma

CONTACT INFORMATION

  • (850) 696 4000
  • 4724 North Davis Highway
    Pensacola, FL 32503

  • 1301 Belleville Avenue, 
    Brewton, Alabama 36426

HOURS

Monday – Friday 8:00 – 5:00

LOCATIONS

NORTH DAVIS

BREWTON, ALABAMA